微信直播

Prof. Katherine Morris:胰腺癌手术并发症的评估与管理

Published at: 2015年第1卷第S1期

邓洁莹
关键词:

编者按:2017年11月17日-18日,由上海交通大学医学院附属新华医院主办的第八届新华国际外科论坛在上海顺利召开。此次论坛邀请了近百名国内外专家针对当前外科医疗最新技术、最新进展及热点作精彩报告。此次会议中,来自美国俄勒冈卫生科技大学的Katherine Morris教授作了题为“Assessment and Management of Co-Morbidities in Pancreatic Cancer Surgery”的精彩演讲。AME编辑在会后也有幸邀请到Morris教授接受简短的访谈,听听她对胰腺癌手术并发症的评估与管理的看法。

人物聚焦:Katherine Morris

Katherine Morris, Associate Professor,Department of Surgery,Oregon Health and Science University (OHSU).

After completing a mathematics degree at the University of Washington, Dr. Morris studied medicine at Oregon Health and Science University (OHSU), where her interest was drawn to surgery.  During her training she was particularly affected by her rotations in cancer surgery, where her patients’ stories, concerns, triumphs, and heartbreak inspired her. During her seven years of general surgery residency at OHSU Dr. Morris completed two years of research in surgical oncology (cancer surgery).

After completing her general surgery residency, Dr. Morris completed a two-year surgical oncology fellowship at Memorial Sloan Kettering Cancer Center in New York, one of the world's leading cancer centers. Here she worked with masters in the field while helping patients with complex pancreas, liver, and metastatic colon cancers. This training emphasized multidisciplinary treatment of cancer, where close coordination between sub-specialists produces the best possible outcomes.

She then practiced in Portland, Oregon, for five years before taking a position at the University of New Mexico in 2010. There she expanded her efforts in laboratory based cancer research and was awarded an American Cancer Society grant to further her work. She joined the University of Oklahoma and Stephenson Cancer Center as an associate professor of surgery and the G. Rainey Williams chair for surgical research in the fall of 2016.

采访中,Morris教授(图1)提到自己对胰腺癌的关注是由于她个人十分享受在胰腺癌领域不断探索、研究的过程。此外,在专科医师培训过程中,能与全国甚至是世界顶尖的医生共事,更是让她热爱这份工作。关于胰腺癌手术并发症,Morris教授简单概括为出血、胰瘘甚至是死亡。相对应的预防措施有在术前增强患者身体素质以及在术后密切观察、随访。

Morris教授在胰腺癌治疗以及并发症防治方面有着多年的临床经验,但她表示目前胰腺癌患者的普遍预后都较差,因此胰腺癌治疗也面临不少难点。Morris教授表示目前最棘手的问题是医生仅凭现有技术无法准确判断患者的预后情况,这就说明患者处于随时可能出现并发症的危险中。尽管Morris教授与她的团队已经在胰腺癌治疗方面做了多年努力,但获得的突破性进展却不多。她希望在未来的5到10年内,局部免疫微环境如何与肿瘤细胞相互作用这个难题能被攻克,这将使胰腺癌治疗向前迈进一大步。

图1. Katherine Morris教授在接受采访

欲知更多精彩内容,请点击下方视频。


采访问题

1. As we know your research interest is hepatobiliary and pancreatic oncologic surgery, would you like to share why you focus on the pancreatic oncologic surgery in your clinical practice?

2. Could you please briefly introduce the complications of pancreatic cancer surgery? What factors the surgeon should pay attention when they operate pancreatic cancer surgery?

3. Pancreatic cancer is a tumor with a high degree of malignancy and its morbidity and mortality have increased significantly in recent years. In your opinion, what is the biggest obstacle in the surgery and treatment?

4. What’s your view on the phenomenon that the morbidity crowd with pancreatic cancer becomes youth-oriented?

5. How is current clinical situation in treating pancreatic cancer? What do you think of the future development in the treatment of pancreatic cancer?


采写编辑:邓洁莹,第二届追梦计划见习编辑

视频编辑:麦雪芳,AME Publishing Company

学术审核:张开平,AME Publishing Company

责任编辑:徐畅、许梦杨,AME Publishing Company

comments powered by Disqus

附件